Supplemental File: Tumor-infiltrating lymphocytes as a predictive biomarker of cutaneous immune-related adverse events after immune checkpoint blockade in patients with advanced melanoma

Published: 6 March 2023| Version 1 | DOI: 10.17632/bp7f6gn8ks.1
Contributors:
Michael Stephens, Maria Asdourian, Ted Jacoby, Nishi Shah, Leah Thompson, Tracey Otto, Yevgeniy Semenov, Kerry Reynolds, Ryan Sullivan, Ruth Foreman, Steven Chen

Description

This file contains additional details on study design and statistical methodology.

Files

Categories

Dermatology, Oncology, Biomarkers, Toxicity, Melanoma, Immune Checkpoint Blockade, Tumor Infiltrating Lymphocyte, Immune Checkpoint Inhibitor

Licence